The virus filtration market in Europe is estimated to be worth USD 2.58 billion by 2029 from USD 1.50 billion in 2024, growing at a CAGR of 11.57% from 2024 To 2029.
The growing adoption of virus filtration techniques by pharmaceutical companies is majorly accelerating the growth of the virus filtration market in Europe. The increasing patient population suffering from chronic diseases is increasing the need to develop novel drugs and advanced drugs that help reduce the mortality rate among the population. In Europe, 86% of deaths are due to chronic diseases such as cardiovascular disease, cancer, diabetes, and others. In addition, the growing usage of virus filtration in biopharmaceutical companies is anticipated to aid regional market growth. Virus clearance plays a significant role in the development of safe drugs. Furthermore, virus filters help in playing a significant role in defending against the introduction of adventitious viruses into an important class of medicines. Throughout the development process of a drug, it must undergo a virus filtration process from the raw material to the desired product for effective results and no adverse effects after using the drugs.
In addition, the growing number of R&D activities around virus filtration techniques to develop more advanced and effective techniques is expected to propel the market growth in Europe. Nano filters are one of the types of virus filtration which are specially designed to remove the virus. The continuation of the spread of coronavirus among a large population and the development of new variants resulted in the development of different types of virus filtration systems that help maintain people's health in crowded places. Researchers and key players are focusing on developing devices used for water filtration, filtration devices at trains, etc., to remove the virus.
Furthermore, increasing investments in virus filtration devices, the presence of primary key players in the European region, and the presence of reimbursement policies are estimated to fuel the growth rate of the European virus filtration market. Additionally, increasing awareness programs about the benefits of virus filtration technology in various sectors by the government and other healthcare organizations also demand the use of virus filtration systems.
However, stringent approvals for virus filtration products in the European region primarily hamper the growth of the European virus filtration market. In addition, the unavailability of virus filtration devices in some areas due to lack of production is another factor hindering the market growth. In addition, competition between the manufacturers in the region to provide a virus filtration system at an affordable price may challenge the growth of the market in this region.
This research report on the European virus filtration market has been segmented & sub-segmented into the following categories:
By Product:
By Technology:
By Application:
By End-Use:
By Country:
Geographically, the European region occupied the second-largest worldwide market share in 2021. During the forecast period, the European market is predicted to showcase a healthy CAGR owing to the increasing adoption of advanced infrastructure in the healthcare and pharmaceutical sector. For instance, during the Covid-19 pandemic, many hospitals in Europe preferred to have virus filtration systems to reduce the spread of the coronavirus among patients, healthcare providers, and healthcare workers.
The UK market is estimated to capture the leading share of the European market during the forecast period owing to the growing number of product approvals. In addition, the OVER company launched an advanced sustainable filter-free air purification system named CrossField in 2021, which helps combat airborne viruses and bacteria, including COVID-19.
The German market is expected to showcase a notable CAGR in the coming years. Increasing virus filter training services centres in Germany is primarily driving the market growth in Germany. In addition, due to increasing technological advancements, most people need to know about the working process for better results in virus filtration devices. Furthermore, increasing manufacturing units in the region fuels the market growth in Germany.
KEY MARKET PLAYERS:
Asahi Kasei Medical Co., Ltd., WuXi PharmaTech, Charles River Laboratories International, Inc., GE Healthcare, Lonza Group Ltd., Clean Cells, Merck KGaA, Sartorius, Danaher, and Thermo Fisher Scientific Inc. are some of the prominent players in the European virus filtration market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region